GK
Gustafson Kurt A
首席财务官
OtherM
内部人交易记录
首席财务官尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Gustafson Kurt A, 首席财务官. Officer active across 4 companies, notably Spectrum Pharmaceuticals INC. In total, 24 reports have been recorded. Split: 1 buy · 4 sells. Total volume traded: €108k. History available since 23 February 2022. The latest transaction was filed on 16 June 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Gustafson Kurt A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报24 总计
10,302 股0Common StockSEC:0001462354-26-000006:0
13,542 股0Common StockSEC:0001628280-26-024133:0
6,913 股@ US$1.4910.4% 占其流量Common StockSEC:0001628280-26-024133:1
13,542 股0Common StockSEC:0001628280-25-016989:0
23,244 股0Common StockSEC:0001628280-25-016048:0
13,541 股0Common StockSEC:0001846253-25-000014:0
27,585 股0Common StockSEC:0001846253-25-000005:0
46,501 股Common StockSEC:0001846253-24-000095:0
2,503 股@ US$20.6823.8% 占其流量Common StockSEC:0001127602-24-024676:0
5,986 股0Common StockSEC:0001127602-24-018829:0
13,541 股Common StockSEC:0002001011-24-000046:0
23,254 股Common StockSEC:0002001011-24-000040:0
15,000 股@ US$10.7376.2% 占其流量Common StockSEC:0001127602-24-009007:0
46,503 股Common StockSEC:0002001011-23-000010:0
5,007 股0Common StockSEC:0001127602-23-019288:0
40,625 股0Common StockSEC:0001846253-23-000043:0
8,042 股@ US$3.6835.8% 占其流量Common StockSEC:0001846253-23-000035:0
139,504 股0Common StockSEC:0000899243-23-001021:0
6,733 股@ US$3.3528.5% 占其流量Common StockSEC:0000899243-22-037742:0
10,000 股@ US$2.8135.7% 占其流量Common StockSEC:0000899243-22-037153:0
160,062 股Common StockSEC:0000899243-22-035053:0
17,792 股0Common StockSEC:0000899243-22-035057:0
20,653 股@ US$0.70551.5% 占其流量Common Stock, $0.001 par valueSEC:0001209191-22-019297:0
20,215 股@ US$0.70348.5% 占其流量Common Stock, $0.001 par valueSEC:0001209191-22-012804:0
About Gustafson Kurt A
Kurt A. Gustafson is the Chief Financial Officer at SPECTRUM PHARMACEUTICALS INC. He is responsible for the financial management of the company, including financial planning, risk management, and financial reporting. His expertise is essential for ensuring the company's financial health.